Загрузка...
Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics
Hydroxyurea is currently the only FDA-approved drug that ameliorates the pathophysiology of sickle cell anemia. Unfortunately, substantial interpatient variability in the pharmacokinetics (PK) of hydroxyurea may result in variation of the drug's efficacy. However, little is known about mechanis...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Physiological Society
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882360/ https://ncbi.nlm.nih.gov/pubmed/23986199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00232.2013 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|